Skip to main content
. 2022 Jun 13;34(6):494–502. doi: 10.1016/j.sdentj.2022.06.002

Table 5.

Changes in GCF IL-1β (Gingival Crevicular Fluid Interleukin 1 beta) levels in the Intervention and Placebo groups between the three measurement intervals measured in pictograms per millilitre (pg/ml). Intragroup comparison by Paired samples T-test. Intergroup comparison using independent sample’s T test.

GCF IL-1β levels
Intervention Mean SD Mean SD P-value
0 to 30 111.91 74.45 65.97 48.76 0.009** −45.94
30 to 60 60.56 42.95 70.99 43.28 0.314 10.43
0 to 60 114.14 73.68 67.49 36.53 0.002** −46.65
Placebo
0 to 30 97.83 64.72 61.48 42.93 0.007** −36.35
30 to 60 67.74 48.70 67.48 37.20 0.983 −0.26
0 to 60 101.38 65.45 70.99 43.28 0.056 −30.39



Intervention
Placebo
Mean SD Mean SD P-value

0 112.20 73.17 97.83 64.72 0.424
30 65.97 48.76 61.48 42.93 0.708
60 67.49 36.53 70.99 43.28 0.742
0 to 30 45.94 87.48 36.35 67.90 0.639
30 to 60 0.26 64.57 −10.43 53.75 0.504
0 to 60 46.65 74.28 30.39 80.67 0.432

*P < 0.05 ** P < 0.01.